BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 16009045)

  • 21. Inhibition of simian/human immunodeficiency virus replication in CD4+ T cells derived from lentiviral-transduced CD34+ hematopoietic cells.
    Braun SE; Wong FE; Connole M; Qiu G; Lee L; Gillis J; Lu X; Humeau L; Slepushkin V; Binder GK; Dropulic B; Johnson RP
    Mol Ther; 2005 Dec; 12(6):1157-67. PubMed ID: 16168713
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Retroviral vector insertions in T-lymphocytes used for suicide gene therapy occur in gene groups with specific molecular functions.
    Giordano FA; Fehse B; Hotz-Wagenblatt A; Jonnakuty S; del Val C; Appelt JU; Nagy KZ; Kuehlcke K; Naundorf S; Zander AR; Zeller WJ; Ho AD; Fruehauf S; Laufs S
    Bone Marrow Transplant; 2006 Aug; 38(3):229-35. PubMed ID: 16785865
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Lentiviral and MLV based retroviral vectors for ex vivo and in vivo gene transfer.
    Blesch A
    Methods; 2004 Jun; 33(2):164-72. PubMed ID: 15121171
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Lentivirus vectors: difficulties and hopes before clinical trials.
    Kafri T
    Curr Opin Mol Ther; 2001 Aug; 3(4):316-26. PubMed ID: 11525555
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A phase I/II clinical trial of beta-globin gene therapy for beta-thalassemia.
    Bank A; Dorazio R; Leboulch P
    Ann N Y Acad Sci; 2005; 1054():308-16. PubMed ID: 16339679
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Rapid 1-hour transduction of whole bone marrow leads to long-term repopulation of murine recipients with lentivirus-modified hematopoietic stem cells.
    Kurre P; Anandakumar P; Kiem HP
    Gene Ther; 2006 Feb; 13(4):369-73. PubMed ID: 16208421
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Lessons learned from gene therapy concerning and the use of integrating vectors and the possible risk of insertional oncogenesis.
    Cichutek K
    Dev Biol (Basel); 2006; 123():29-34; discussion 55-73. PubMed ID: 16566434
    [No Abstract]   [Full Text] [Related]  

  • 28. Lentiviruses in gene therapy clinical research.
    Connolly JB
    Gene Ther; 2002 Dec; 9(24):1730-4. PubMed ID: 12457288
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A new direction for gene therapy: intrathymic T cell-specific lentiviral gene transfer.
    Seggewiss R; Dunbar CE
    J Clin Invest; 2005 Aug; 115(8):2064-7. PubMed ID: 16075048
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of HIV- and EIAV-based vectors on their efficiency in transducing murine and human hematopoietic repopulating cells.
    Siapati EK; Bigger BW; Miskin J; Chipchase D; Parsley KL; Mitrophanous K; Themis M; Thrasher AJ; Bonnet D
    Mol Ther; 2005 Sep; 12(3):537-46. PubMed ID: 16099415
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Expression of human factor IX gene in murine plasma through lentiviral vector-infected haematopoietic stem cells.
    Chen H; Yao H; Huang L; Shen Q; Jia W; Xue J
    Clin Exp Pharmacol Physiol; 2006 Dec; 33(12):1196-201. PubMed ID: 17184501
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Glycoprotein Ibalpha promoter drives megakaryocytic lineage-restricted expression after hematopoietic stem cell transduction using a self-inactivating lentiviral vector.
    Lavenu-Bombled C; Izac B; Legrand F; Cambot M; Vigier A; Massé JM; Dubart-Kupperschmitt A
    Stem Cells; 2007 Jun; 25(6):1571-7. PubMed ID: 17379771
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Design and production of retro- and lentiviral vectors for gene expression in hematopoietic cells.
    Schambach A; Swaney WP; van der Loo JC
    Methods Mol Biol; 2009; 506():191-205. PubMed ID: 19110628
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The US and EU regulatory perspectives on the clinical use of hematopoietic stem/progenitor cells genetically modified ex vivo by retroviral vectors.
    Wilson CA; Cichutek K
    Methods Mol Biol; 2009; 506():477-88. PubMed ID: 19110646
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Lentiviral vectors].
    Spirin PV; Vil'gelm AE; Prasolov VS
    Mol Biol (Mosk); 2008; 42(5):913-26. PubMed ID: 18988539
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Transient gene expression mediated by integrase-defective retroviral vectors.
    Yu SS; Dan K; Chono H; Chatani E; Mineno J; Kato I
    Biochem Biophys Res Commun; 2008 Apr; 368(4):942-7. PubMed ID: 18279658
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Hematopoietic malignancies and gene therapy].
    Ozawa K
    Gan To Kagaku Ryoho; 2003 Apr; 30(4):478-82. PubMed ID: 12722677
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Lentiviral vector-mediated gene delivery into human embryonic stem cells.
    Gropp M; Reubinoff B
    Methods Enzymol; 2006; 420():64-81. PubMed ID: 17161694
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Non-HIV lentiviral vectors: interview with Alan Kingsman.
    Kingsman A
    J Gene Med; 1999; 1(6):441-3. PubMed ID: 10753070
    [No Abstract]   [Full Text] [Related]  

  • 40. Medicine. Gene therapy--new challenges ahead.
    Williams DA; Baum C
    Science; 2003 Oct; 302(5644):400-1. PubMed ID: 14563994
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.